Your session is about to expire
← Back to Search
Biological
Autocontrolled Arm for Male Pattern Baldness
Phase 1 & 2
Waitlist Available
Led By Maryanne M. Senna, MD
Research Sponsored by Santiste Medical Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 6 and month 8
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare the effects of two different types of platelet-rich plasma (PRP) on male patients with androgenic alopecia (AGA). One type of PRP will be activated with pulsed electrical fields (PEFA-PRP), while the other will not be activated (non-activated PRP). The trial will assess the clinical benefit of PEFA-PRP versus non-activated PRP treatment.
Eligible Conditions
- Male Pattern Baldness
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ month 6 and month 8
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6 and month 8
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in hair density and hair regrowth
Measurement of hair regrowth
Secondary study objectives
Clinical progression of treatment as determined by principal investigator
Clinical progression of treatment as determined by subject
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Autocontrolled ArmExperimental Treatment1 Intervention
The subject will be treated with both the experimental treatment and the active comparator.
Find a Location
Who is running the clinical trial?
Santiste Medical Inc.Lead Sponsor
Maryanne M. Senna, MDPrincipal InvestigatorLahey Hospital & Medical Center
Share this study with friends
Copy Link
Messenger